These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14739238)

  • 21. In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors.
    Salmas RE; Unlu A; Yurtsever M; Noskov SY; Durdagi S
    J Enzyme Inhib Med Chem; 2016; 31(1):112-20. PubMed ID: 26083304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.
    Hopkins TA; Shi Y; Rodriguez LE; Solomon LR; Donawho CK; DiGiammarino EL; Panchal SC; Wilsbacher JL; Gao W; Olson AM; Stolarik DF; Osterling DJ; Johnson EF; Maag D
    Mol Cancer Res; 2015 Nov; 13(11):1465-77. PubMed ID: 26217019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis.
    Langelier MF; Pascal JM
    Curr Opin Struct Biol; 2013 Feb; 23(1):134-43. PubMed ID: 23333033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis.
    Costantino G; Macchiarulo A; Camaioni E; Pellicciari R
    J Med Chem; 2001 Nov; 44(23):3786-94. PubMed ID: 11689065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-targeted organometallic ruthenium(II)-arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity.
    Wang Z; Qian H; Yiu SM; Sun J; Zhu G
    J Inorg Biochem; 2014 Feb; 131():47-55. PubMed ID: 24239912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
    Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
    FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
    Parsons JL; Dianova II; Allinson SL; Dianov GL
    FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of anti-peptide antibodies directed towards the automodification domain and apoptotic fragment of poly (ADP-ribose) polymerase.
    Duriez PJ; Desnoyers S; Hoflack JC; Shah GM; Morelle B; Bourassa S; Poirier GG; Talbot B
    Biochim Biophys Acta; 1997 Feb; 1334(1):65-72. PubMed ID: 9042367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
    Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3.
    Lindgren AE; Karlberg T; Thorsell AG; Hesse M; Spjut S; Ekblad T; Andersson CD; Pinto AF; Weigelt J; Hottiger MO; Linusson A; Elofsson M; Schüler H
    ACS Chem Biol; 2013 Aug; 8(8):1698-703. PubMed ID: 23742272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).
    Sunderland PT; Woon EC; Dhami A; Bergin AB; Mahon MF; Wood PJ; Jones LA; Tully SR; Lloyd MD; Thompson AS; Javaid H; Martin NM; Threadgill MD
    J Med Chem; 2011 Apr; 54(7):2049-59. PubMed ID: 21417348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nondenaturing purification scheme for the DNA-binding domain of poly(ADP-ribose) polymerase, a structure-specific DNA-binding protein.
    Ruscetti T; Newman J; Peat TS; Francis J; Nolan R; Terwilliger TC; Peterson SR; Lehnert BE
    Protein Expr Purif; 1998 Oct; 14(1):79-86. PubMed ID: 9758754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and biophysical studies of human PARP-1 in complex with damaged DNA.
    Lilyestrom W; van der Woerd MJ; Clark N; Luger K
    J Mol Biol; 2010 Feb; 395(5):983-94. PubMed ID: 19962992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the effect of PARP-1 flexibility in docking studies.
    Antolin AA; Carotti A; Nuti R; Hakkaya A; Camaioni E; Mestres J; Pellicciari R; Macchiarulo A
    J Mol Graph Model; 2013 Sep; 45():192-201. PubMed ID: 24056306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(ADP-ribose) polymerase (PARP-1) and p53 independently function in regulating double-strand break repair in primate cells.
    Süsse S; Scholz CJ; Bürkle A; Wiesmüller L
    Nucleic Acids Res; 2004; 32(2):669-80. PubMed ID: 14757832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
    Zeng H; Zhang H; Jang F; Zhao L; Zhang J
    Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells.
    Le TV; Suh JH; Kim N; Park HJ
    Bioorg Med Chem Lett; 2013 May; 23(9):2642-6. PubMed ID: 23522835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain.
    Dawicki-McKenna JM; Langelier MF; DeNizio JE; Riccio AA; Cao CD; Karch KR; McCauley M; Steffen JD; Black BE; Pascal JM
    Mol Cell; 2015 Dec; 60(5):755-768. PubMed ID: 26626480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.
    Zhou Q; Ji M; Zhou J; Jin J; Xue N; Chen J; Xu B; Chen X
    Biochem Pharmacol; 2016 May; 107():29-40. PubMed ID: 26920250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical association of poly(ADP-ribose) polymerase-1 and its apoptotic peptide fragments with DNA polymerase beta.
    Confer NF; Kumari SR; Alvarez-Gonzalez R
    Chem Biodivers; 2004 Oct; 1(10):1476-86. PubMed ID: 17191791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.